Hyperlipidemia is one of the most frequently diagnosed metabolic disorders in the United States and remains a major risk factor for cardiovascular disease, stroke, and peripheral arterial disease. According to the Centers for Disease Control and Prevention (CDC), millions of adults have elevated cholesterol levels, making lipid screening and treatment an essential part of preventive healthcare.
The U.S. Preventive Services Task Force (USPSTF) recommends routine cholesterol screening for adults aged 40 to 75 who have cardiovascular risk factors. From a coding and billing perspective, accurate diagnosis reporting begins with the E78 category, which includes disorders of lipoprotein metabolism and other lipid abnormalities.
Correct ICD-10 code selection is important because it supports medical necessity, improves claim accuracy, reduces denials, and strengthens risk-adjustment reporting. This guide explains the hyperlipidemia ICD-10 code (E78.5) and the complete E78 family, including code descriptions, clinical use, laboratory pairings, and common billing considerations for FY 2026.
What Is the ICD-10 Code for Hyperlipidemia?
The ICD-10-CM code most commonly used for hyperlipidemia is E78.5 – Hyperlipidemia, unspecified.
This code belongs to:
- Chapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00–E89)
- Category E78: Disorders of lipoprotein metabolism and other lipidemias
E78.5 is assigned when the provider documents elevated lipid levels but does not specify whether the abnormality involves cholesterol, triglycerides, or a mixed lipid disorder.
E78 Family of Hyperlipidemia Codes
| ICD-10 Code | Description | Typical Lipid Abnormality |
|---|---|---|
| E78.00 | Pure hypercholesterolemia, unspecified | Elevated cholesterol only |
| E78.010 | Homozygous familial hypercholesterolemia | Severe inherited disorder |
| E78.011 | Heterozygous familial hypercholesterolemia | Common inherited disorder |
| E78.019 | Familial hypercholesterolemia, unspecified | Genetic type not identified |
| E78.1 | Pure hyperglyceridemia | Elevated triglycerides only |
| E78.2 | Mixed hyperlipidemia | Elevated cholesterol and triglycerides |
| E78.3 | Hyperchylomicronemia | Increased chylomicrons |
| E78.41 | Elevated lipoprotein(a) | High Lp(a) levels |
| E78.49 | Other hyperlipidemia | Other lipid disorders |
| E78.5 | Hyperlipidemia, unspecified | Lipid type not documented |
| E78.9 | Disorder of lipoprotein metabolism, unspecified | Broad unspecified diagnosis |
Whenever laboratory findings identify a specific lipid abnormality, coders should report the most precise code rather than defaulting to E78.5.
How Is E78.5 Defined?
E78.5 – Hyperlipidemia, unspecified describes elevated blood lipid levels when the exact type of lipid disorder is not documented.
This code is appropriate when the medical record states:
- Hyperlipidemia
- Elevated lipids
- Dyslipidemia (without additional detail)
The code should not be used if documentation clearly identifies:
- Elevated cholesterol only
- Elevated triglycerides only
- Combined lipid abnormalities
- Familial lipid disorders
E78.5 remains a billable and valid ICD-10-CM code for FY 2026.
Why Is E78.5 Frequently Overused?
Many providers and coders assign E78.5 even when laboratory results support a more specific diagnosis.
Examples include:
- High LDL cholesterol with normal triglycerides → E78.00
- High triglycerides with normal cholesterol → E78.1
- Elevated LDL and elevated triglycerides → E78.2
Excessive use of unspecified codes may create several problems:
1. Increased Payer Review
Insurance carriers monitor coding patterns and may question practices that rely heavily on unspecified diagnoses.
2. Medical Necessity Challenges
Specific lipid diagnoses more clearly justify laboratory testing, follow-up visits, and medication management.
3. Risk Adjustment Limitations
Detailed diagnosis coding improves documentation quality and supports value-based care reporting.
Hyperlipidemia vs Hypercholesterolemia vs Dyslipidemia
These terms are often used interchangeably, but they do not mean exactly the same thing.
| Term | Definition | Common ICD-10 Coding |
|---|---|---|
| Hyperlipidemia | General increase in blood lipids | E78.5 or specific E78 codes |
| Hypercholesterolemia | Elevated cholesterol only | E78.00 or E78.01- |
| Dyslipidemia | Any abnormal lipid level | Depends on documentation |
Dyslipidemia is the broadest clinical term because it can include both elevated and reduced lipid levels.
Complete Overview of E78 Hyperlipidemia Codes
E78.00 – Pure Hypercholesterolemia
E78.00 is assigned when cholesterol is elevated but triglyceride levels remain within normal limits.
This code commonly applies to patients with:
- High LDL cholesterol
- Elevated total cholesterol
- Normal triglyceride values
Familial Hypercholesterolemia Codes (FY 2026 Update)
The FY 2026 ICD-10-CM update expanded familial hypercholesterolemia coding into three separate diagnoses:
| ICD-10 Code | Description |
|---|---|
| E78.010 | Homozygous familial hypercholesterolemia |
| E78.011 | Heterozygous familial hypercholesterolemia |
| E78.019 | Familial hypercholesterolemia, unspecified |
This change allows providers to better identify inherited lipid disorders and document disease severity.
Familial hypercholesterolemia is associated with a significantly increased risk of premature atherosclerotic cardiovascular disease (ASCVD).
E78.1 – Pure Hyperglyceridemia
E78.1 represents isolated elevation of triglycerides with normal cholesterol values.
Common causes include:
- Diabetes mellitus
- Obesity
- Alcohol use
- Genetic lipid disorders
- Certain medications
Documentation should confirm that triglycerides are elevated while cholesterol levels remain normal.
E78.2 – Mixed Hyperlipidemia
E78.2 describes simultaneous elevation of cholesterol and triglycerides.
This is one of the most common lipid diagnoses in cardiology and primary care settings.
Examples supporting E78.2 include:
- LDL: 190 mg/dL
- Triglycerides: 230 mg/dL
Both lipid abnormalities must be documented to support this code.
E78.3 – Hyperchylomicronemia
E78.3 identifies elevated chylomicron levels, usually associated with severe triglyceride disorders or inherited metabolic conditions.
This diagnosis is uncommon but clinically significant because severe cases may increase the risk of pancreatitis.
E78.41 – Elevated Lipoprotein(a)
E78.41 is used for elevated lipoprotein(a), commonly abbreviated as Lp(a).
Lp(a) is a genetically determined cardiovascular risk marker associated with:
- Premature coronary artery disease
- Stroke
- Aortic stenosis
Testing for Lp(a) is commonly reported using:
- CPT 83695 – Lipoprotein(a) measurement
As awareness of genetic cardiovascular risk factors increases, E78.41 is becoming more important in preventive cardiology and lipid management programs.
E78.49 – Other Hyperlipidemia
E78.49 applies to lipid abnormalities that do not fit into the standard categories of:
- Pure hypercholesterolemia
- Hypertriglyceridemia
- Mixed hyperlipidemia
- Familial hypercholesterolemia
Provider documentation should clearly describe the lipid disorder to support this code.
Key Coding Takeaway
The E78 family provides coders with detailed options for reporting lipid disorders. While E78.5 remains a valid diagnosis code, providers should select more specific codes whenever clinical documentation and laboratory results support them.
Specific coding improves:
- Claim accuracy
- Medical necessity support
- Risk adjustment reporting
- Data quality
- Reimbursement outcomes
For FY 2026, particular attention should be given to the updated familial hypercholesterolemia codes, which offer improved documentation of inherited lipid disorders.
